Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
Platinum-based chemotherapies, such as cisplatin, play a large role in cancer treatment. The development of resistance and treatment toxicity creates substantial barriers to disease control, yet. To enhance the therapeutic index of cisplatin-based chemotherapy, it is imperative to circumvent resista...
Main Authors: | Robert Csaba Kiss, Fen Xia, Scarlett Acklin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/15/8199 |
Similar Items
-
DNA repair pathways and cisplatin resistance: an intimate relationship
by: Clarissa Ribeiro Reily Rocha, et al.
Published: (2018-09-01) -
Advances of DNA Damage Repair and Cisplatin Resistance Mechanisms in Lung Cancer
by: Chunlan TANG, et al.
Published: (2011-12-01) -
Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons
by: Jewel L. Podratz, et al.
Published: (2011-03-01) -
The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment
by: Scarlett Acklin, et al.
Published: (2021-02-01) -
Systems Genetics of DNA Damage Tolerance – Cisplatin, RAD5 & CRISPR-mediated Nonsense
by: Bryant, Eric Edward
Published: (2019)